Trisha Suppes, MD, PhD

Publication Details

• Open-label adjunctive topiramate in the treatment of bipolar disorders.

  McElroy SL, Suppes T, Keck PE, Frye MA, Denicoff KD, Altshuler LL, Brown ES, Nolen WA, Kupka RW, Rochussen J, Leverich GS, Post RM. Biol Psychiatry. 2000; 47 (12): 1025-33

  To preliminarily explore the spectrum of effectiveness and tolerability of the new antiepileptic drug topiramate in bipolar disorder, we evaluated the response of 56 bipolar outpatients in the Stanley Foundation Bipolar Outcome Network (SFBN) who had been treated with adjunctive topiramate in an open-label, naturalistic fashion.

  PubMedID: 10862801